Drug Trial Radar · NCT00114868
Vitamin A Supplementation in Newborns Study
Last checked: Nov 20, 2026Latest source record: Mar 3, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
14,035
Actual
Start
Jun 1998
Primary completion
Apr 2001
Study completion Apr 2001
Sponsor
- Lead sponsor
- Johns Hopkins Bloomberg School of Public HealthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Aravind Centre for Women and Children, Madurai, Tamil Nadu, India
- First posted
- Jun 20, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 1 minute, up to 2 weeks
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study was a randomized, community-based trial testing whether dosing newborn infants in the first few days after delivery with a large dose of vitamin A could reduce early infant morbidity, mortality and improve growth. Pregnant women in 2 districts of Tamil Nadu State in southern India were identified and recruited for participation. When the child was born, study staff were notified and traveled to the house to collect information and provide the vitamin A or placebo dose. Children were visited every two weeks until they were 6 months of age to collect information about vital status and morbidity. All children were discharged from the study at 6 months after growth was assessed and they received a 100,000 IU dose of vitamin A.
Conditions
- Infant, Newborn
Interventions
Vitamin ADrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- mortality in first 6 months of life
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Aravind Center for Women and Children
Madurai, Tamil Nadu, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.